EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The selective estrogen receptor modulator bazedoxifene affects the metabolism and functions of human neutrophils

Elena Lonina iD, Florence Léveillé, Pier-Olivier Leblanc, Yann Breton, Étienne Audet-Walsh iD, Martin Pelletier iD

Journal of Leukocyte Biology · 2026

DOI: 10.1093/jleuko/qiag007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Elena Lonina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Immune Diseases Research Program, CHU de Québec-Université Laval Research Center, 2705 boulevard Laurier, T1-49, Québec, QC, Canada G1…. Hauptthemen laut MEDLINE: Neutrophils, Indoles, Selective Estrogen Receptor Modulators. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bazedoxifene is a selective estrogen receptor modulator that is prescribed to menopausal women to treat symptoms of estrogen deficiency. Furthermore, bazedoxifene is being considered for cancer therapeutics due to its ability to block IL-6 signaling. However, various selective estrogen receptor modulators have been shown to dysregulate the activation and functions of immune cells. Neutrophils are critical players during inflammation, and these medications have been shown to modulate neutrophil activity. Hence, we hypothesize that bazedoxifene could interact with neutrophils and affect their functions. We collected neutrophils from healthy female and male donors and treated them with bazedoxifene. We assessed neutrophil viability by flow cytometry and their metabolic activity with an extracellular flux analyzer (Seahorse). The production of cytokines, phagocytosis, and the production of reactive oxygen species were measured by ELISA, the uptake of pHrodo-conjugated Escherichia coli, and luminol chemiluminescence, respectively. Finally, estrogen receptor and kinase inhibitors were used to investigate mechanisms of action. High doses of bazedoxifene compromise neutrophil viability in a sex-dependent manner. However, these concentrations can increase the release of inflammatory cytokines while impairing antimicrobial functions in both sexes. The effects of bazedoxifene on neutrophil function are independent of estrogen receptors but may be partially mediated by p38 MAPK activation. Taken together, bazedoxifene could promote neutrophilic inflammation by releasing chemokines while hindering pathogenic clearance. These observations expand our knowledge of the adverse effects of selective estrogen receptor modulators on immune cells, and they highlight the importance of understanding their activity before becoming repurposed to treat chronic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsIndolesSelective Estrogen Receptor ModulatorsHumansFemaleReactive Oxygen SpeciesMalePhagocytosisCytokinesCell Survival

Stichwörter der Autor:innen

bazedoxifeneenergy metabolisminflammationneutrophilselective estrogen receptor modulator

Substanzen

bazedoxifeneIndolesSelective Estrogen Receptor ModulatorsReactive Oxygen SpeciesCytokines

Autor:innen und Institutionen

  • Infectious and Immune Diseases Research Program, CHU de Québec-Université Laval Research Center, 2705 boulevard Laurier, T1-49, Québec, QC, Canada G1V 4G2.
  • Department of Microbiology-Infectious Disease and Immunology, Faculty of Medicine, Université Laval, 1050 avenue de la Médecine, local 4889, Québec, QC, Canada G1V 0A6.
  • Centre ARThrite, Faculty of Medicine, Université Laval, 2705 boulevard Laurier, Québec, QC, Canada G1V 4G2.
  • Endocrinology and Nephrology Research Program, CHU de Québec-Université Laval Research Center, 2705 boulevard Laurier, R-4714, Québec, QC, Canada G1V 4G2.
  • Department of Molecular Medicine, Faculty of Medicine, Université Laval, 1050 avenue de la Médecine, local 4889, Québec, QC, Canada G1V 0A6.

ORCID-Profile: Elena Lonina, Étienne Audet-Walsh, Martin Pelletier

Förderung

  • National Sciences and Engineering Research Council of Canada

Zitieren

APA

Lonina, E., Léveillé, F., Leblanc, P. O., Breton, Y., Audet-Walsh, É., & Pelletier, M. (2026). The selective estrogen receptor modulator bazedoxifene affects the metabolism and functions of human neutrophils. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag007

Vancouver

Lonina E, Léveillé F, Leblanc PO, Breton Y, Audet-Walsh É, Pelletier M. The selective estrogen receptor modulator bazedoxifene affects the metabolism and functions of human neutrophils. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag007

BibTeX
@article{Lonina2026,
  author = {Lonina, Elena and Léveillé, Florence and Leblanc, Pier-Olivier and Breton, Yann and Audet-Walsh, Étienne and Pelletier, Martin},
  title = {The selective estrogen receptor modulator bazedoxifene affects the metabolism and functions of human neutrophils},
  journal = {Journal of Leukocyte Biology},
  year = {2026},
  doi = {10.1093/jleuko/qiag007}
}
Kostenlos starten →